Aurobindo Pharma Financials Statements
Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios
Financial Year | Jun '26 | ||||
|---|---|---|---|---|---|
Total Qtr Revenue cr | 9,414.58 | ||||
| Other Income Qtr Cr | 264.23 | ||||
| Operating Revenues Qtr | 9,150.35 | ||||
Loading chart... | |||||
Operating Expenses Qtr | 7,269.29 | ||||
Operating Profit Qtr | 1,881.06 | ||||
EBITDA Qtr Cr | 2,105.11 | ||||
Depreciation Qtr | 486.82 | ||||
Net Profit Qtr | 1,032.56 | ||||
Basic EPS Qtr | 17.86 | ||||